Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Pfizer Inc.

NYSE

Market Cap.

163.65B

Avg. Volume

42.68M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Pfizer Inc.!

Still processing it, give me a bit more time...

Pfizer Inc. News

Pfizer Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareDrug Manufacturers - General
pfizer.com

About Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Pfizer Inc. Earnings & Revenue

Pfizer Inc. Financials

Table Compare

Compare PFE metrics with:

   

Earnings & Growth

PFE

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

PFE

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

PFE

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

PFE

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Pfizer Inc. Income

Pfizer Inc. Balance Sheet

Pfizer Inc. Cash Flow

Pfizer Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioBuy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Pfizer Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.6600

Payment DateDividendFrequency
2024-06-140.42Quarterly
2024-03-010.42Quarterly
2023-12-040.41Quarterly
2023-09-050.41Quarterly
2023-06-090.41Quarterly

Historical Market Cap

Shares Outstanding

Pfizer Inc. Executives

NameRole
Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & Chief Executive Officer
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and President of Research & Development
Mr. Aamir MalikExecutive Vice President & Chief U.S. Commercial Officer
Mr. Douglas M. LanklerExecutive Vice President & General Counsel
Mr. David M. DentonChief Financial Officer & Executive Vice President
NameRoleGenderDate of BirthPay
Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & Chief Executive Officer19624.05M
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and President of Research & Development19582.41M
Mr. Aamir MalikExecutive Vice President & Chief U.S. Commercial OfficerMale19761.89M
Mr. Douglas M. LanklerExecutive Vice President & General CounselMale19661.76M
Mr. David M. DentonChief Financial Officer & Executive Vice PresidentMale19651.75M

Pfizer Inc. Insider Trades

Date15 May
NameDAMICO JENNIFER B.
RoleSVP & Controller
TransactionAcquired
TypeA-Award
Shares49
Date15 May
NameBOURLA ALBERT
RoleChairman & CEO
TransactionAcquired
TypeA-Award
Shares18
Date30 Apr
NameDAMICO JENNIFER B.
RoleSVP & Controller
TransactionAcquired
TypeA-Award
Shares55
Date30 Apr
NameBOURLA ALBERT
RoleChairman & CEO
TransactionAcquired
TypeA-Award
Shares20
Date25 Apr
NameQuincey James
RoleDirector
TransactionAcquired
TypeA-Award
Shares8115.598
DateNameRoleTransactionTypeShares
15 MayDAMICO JENNIFER B.SVP & ControllerAcquiredA-Award49
15 MayBOURLA ALBERTChairman & CEOAcquiredA-Award18
30 AprDAMICO JENNIFER B.SVP & ControllerAcquiredA-Award55
30 AprBOURLA ALBERTChairman & CEOAcquiredA-Award20
25 AprQuincey JamesDirectorAcquiredA-Award8115.598

Discover More

Streamlined Academy

Pfizer Inc.

NYSE

Market Cap.

163.65B

Avg. Volume

42.68M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Pfizer Inc. News

Pfizer Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Pfizer Inc. Earnings & Revenue

Pfizer Inc. Income

Pfizer Inc. Balance Sheet

Pfizer Inc. Cash Flow

Pfizer Inc. Financials Over Time

Pfizer Inc. Executives

NameRole
Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & Chief Executive Officer
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and President of Research & Development
Mr. Aamir MalikExecutive Vice President & Chief U.S. Commercial Officer
Mr. Douglas M. LanklerExecutive Vice President & General Counsel
Mr. David M. DentonChief Financial Officer & Executive Vice President
NameRoleGenderDate of BirthPay
Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & Chief Executive Officer19624.05M
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and President of Research & Development19582.41M
Mr. Aamir MalikExecutive Vice President & Chief U.S. Commercial OfficerMale19761.89M
Mr. Douglas M. LanklerExecutive Vice President & General CounselMale19661.76M
Mr. David M. DentonChief Financial Officer & Executive Vice PresidentMale19651.75M

Pfizer Inc. Insider Trades

Date15 May
NameDAMICO JENNIFER B.
RoleSVP & Controller
TransactionAcquired
TypeA-Award
Shares49
Date15 May
NameBOURLA ALBERT
RoleChairman & CEO
TransactionAcquired
TypeA-Award
Shares18
Date30 Apr
NameDAMICO JENNIFER B.
RoleSVP & Controller
TransactionAcquired
TypeA-Award
Shares55
Date30 Apr
NameBOURLA ALBERT
RoleChairman & CEO
TransactionAcquired
TypeA-Award
Shares20
Date25 Apr
NameQuincey James
RoleDirector
TransactionAcquired
TypeA-Award
Shares8115.598
DateNameRoleTransactionTypeShares
15 MayDAMICO JENNIFER B.SVP & ControllerAcquiredA-Award49
15 MayBOURLA ALBERTChairman & CEOAcquiredA-Award18
30 AprDAMICO JENNIFER B.SVP & ControllerAcquiredA-Award55
30 AprBOURLA ALBERTChairman & CEOAcquiredA-Award20
25 AprQuincey JamesDirectorAcquiredA-Award8115.598

Streamlined Academy

Website screenshot
HealthcareDrug Manufacturers - General
pfizer.com

About Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Pfizer Inc.!

Still processing it, give me a bit more time...

Pfizer Inc. Financials

Table Compare

Compare PFE metrics with:

   

Earnings & Growth

PFE

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

PFE

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

PFE

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

PFE

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Pfizer Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.6600

Payment DateDividendFrequency
2024-06-140.42Quarterly
2024-03-010.42Quarterly
2023-12-040.41Quarterly
2023-09-050.41Quarterly
2023-06-090.41Quarterly

Pfizer Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioBuy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More